Medical Condition News

RSS

Treatment is the best way for problem gamblers, says gambling addiction expert

A leading expert on gambling addictions, saying that "prohibition doesn't work," today praised the Illinois Video Gaming Act for addressing the issue head-on by providing funding for treatment programs.

18 Sep 2009

Early detection of Alzheimer's can prevent disease progression

More than 5.3 million Americans are living with Alzheimer's, and every 71 seconds someone in America develops the disease.

18 Sep 2009

AFA welcomes inclusion of cognitive impairment screening in healthcare reform proposal

The Alzheimer's Foundation of America (AFA) today applauded Senate Finance Committee Chairman Max Baucus (D-MT) and Senator Tom Carper (D-DE), who spearheaded the provision, for including cognitive impairment screening for Medicare beneficiaries in Baucus' healthcare reform proposal, "America's Healthy Future Act of 2009."

18 Sep 2009

PSC activation mechanisms help develop novel therapeutic approaches for pancreatic fibrosis

Fibrosis is a key feature of chronic pancreatitis and pancreatic cancer. The extensive deposition of extracellular matrix proteins fosters the development of an exocrine and endocrine organ insufficiency, and accelerates progression of the tumour. Pancreatic stellate cells (PSC) are the principal effector cells in pancreatic fibrosis. They are activated by profibrogenic mediators, which include, for example, cytokines and ethanol metabolites.

18 Sep 2009

Deterioration in brain function following breast cancer therapy has negative effects on quality of life

One of the most problematic side effects of cancer treatment, chemobrain - a range of symptoms including memory loss, inability to concentrate, difficulty thinking and other subtle cognitive changes following chemotherapy - seriously diminishes women's quality of life and daily functioning.

18 Sep 2009

African Americans at higher risk of developing potentially deadly DVT and PE than other ethnic populations

Speaking at the Venous Disease Coalition (VDC) Annual Meeting today, Dr. Garth Graham from the Office of Minority Health at the Department of Health and Human Services followed up on last year's Surgeon General's Call to Action by focusing attention on the African American population which is at significantly increased risk of Deep Vein Thrombosis (DVT) and Pulmonary Embolism (PE).

18 Sep 2009

Lantheus commences Phase 1 study evaluating novel LMI1195 heart failure imaging agent

Lantheus Medical Imaging, Inc., a worldwide leader in diagnostic imaging, today announced the initiation of a Phase 1 clinical study to assess the safety, dosimetry and tolerability of LMI1195, a novel F-18 small molecule tracer for imaging cardiac neuronal function, in healthy subjects, undergoing positron emission tomography (PET) imaging.

17 Sep 2009

CCPHA research reveals the serious health risks of drinking soda

While health officials have long suspected the link between obesity and soda consumption, research released today provides the first scientific evidence of the potent role soda and other sugar-sweetened beverages play in fueling California’s expanding girth.

17 Sep 2009

InterMune and National Jewish Health to collaborate in the research of idiopathic pulmonary fibrosis

InterMune, Inc. (Nasdaq: ITMN) today announced that it will be collaborating with National Jewish Health(R)( )investigators in order to help further the research of inherited genetic factors that may play a role in idiopathic pulmonary fibrosis (IPF). InterMune will provide researchers at National Jewish with access to DNA collected from patients who participated in the Company's Phase 3 clinical trials in IPF for both pirfenidone (CAPACITY trials) and Actimmune(R) (interferon gamma-1b) (INSPIRE).

17 Sep 2009

Essilor announces first-ever eco-friendly eyewear

Back to school is an important time for families and eyesight, as many schools require eye exams and teachers notice vision needs through classroom activities. With the start of a new school year, it's also a chance for families to kick start a new routine to support the environment and establish every day green habits.

17 Sep 2009

Intarcia's ITCA 650 phase 2 study in type 2 diabetes begins patient enrollment

Intarcia Therapeutics, Inc. today announced the start of enrollment for a phase 2 study comparing its proprietary drug candidate ITCA 650 (DUROS continuous delivery of exenatide) with Byetta, an FDA-approved twice-daily injection form of exenatide.

17 Sep 2009

Study: HBV genotype is not linked to hepatocellular carcinoma

Previous studies revealed that HBV genotypes as well as mutations in the core promoter, precore or HBx gene have been shown to have an association with the clinical outcome of liver disease, however, this is still controversial. It is likely that this depends on the HBV genotype distribution in certain region.

17 Sep 2009

Educational initiative proves successful in identifying and diagnosing fibromyalgia

According to The Johns Hopkins University School of Medicine, the Fibromyalgia Circle of Care Initiative has achieved dramatic success in heightening awareness, diagnosis and best practice treatment of fibromyalgia – a complex and chronic pain disorder that plagues an estimated 10 million Americans.

17 Sep 2009

UPV provides new model to recognize postnatal depression

Worldwide, 13% of women who give birth suffer from postnatal depression, which causes a significant deterioration in a mother's quality of life and her ability to care for her baby. Now, Spanish researchers have developed a model to diagnose this illness with a predictive power of 80% - the best result to date for this kind of depression.

17 Sep 2009

Cancer patients struggles with huge drug costs

Canada's patchwork system of drug coverage is leading to financial hardship for many cancer patients, says a Canadian Cancer Society report released today.

17 Sep 2009

Deterioration in brain function following breast cancer therapy affects quality of life: Study

17 Sep 2009

GENova Biotherapeutics signs collaboration deal with Beckpharma

GENova Biotherapeutics Inc. ("GENova"), a biotechnology company that develops novel therapeutic proteins that disrupt the advance of life-threatening cancers, today announced it has signed a collaboration deal with Beckpharma Ltd.

17 Sep 2009

Coffe Break campaign by Alzheimer Society to raise funds to support people with dementia

Today the Alzheimer Society gives greater meaning to your daily dose of caffeine. By purchasing a cup of coffee during the Alzheimer Coffee Break(R) fundraiser you will be supporting critical programs and services for the half million Canadians living with Alzheimer's disease or related dementias.

17 Sep 2009

The Ontario Government must act to reduce the financial barrier to mental health services: MFH

Financial barriers can be immense for people who suffer from mental illness and the Ontario Government has an opportunity to act now. The All-Party Committee on Mental Health and Addictions is hearing from groups and individuals on what should be included in a strategy for the province.

17 Sep 2009

CHUM installs CyberKnife system for effective cancer treatment in Canada

Accuray Incorporated, a global leader in the field of radiosurgery today announced that Centre Hospitalier de l'Universite de Montreal (CHUM) has installed a CyberKnife(R) Robotic Radiosurgery System at Hopital Notre-Dame du CHUM, in Montreal, Canada.

17 Sep 2009

Medical Condition News

Treatment is the best way for problem gamblers, says gambling addiction expert

Early detection of Alzheimer's can prevent disease progression

AFA welcomes inclusion of cognitive impairment screening in healthcare reform proposal

PSC activation mechanisms help develop novel therapeutic approaches for pancreatic fibrosis

Deterioration in brain function following breast cancer therapy has negative effects on quality of life

African Americans at higher risk of developing potentially deadly DVT and PE than other ethnic populations

Lantheus commences Phase 1 study evaluating novel LMI1195 heart failure imaging agent

CCPHA research reveals the serious health risks of drinking soda

InterMune and National Jewish Health to collaborate in the research of idiopathic pulmonary fibrosis

Essilor announces first-ever eco-friendly eyewear

Intarcia's ITCA 650 phase 2 study in type 2 diabetes begins patient enrollment

Study: HBV genotype is not linked to hepatocellular carcinoma

Educational initiative proves successful in identifying and diagnosing fibromyalgia

UPV provides new model to recognize postnatal depression

Cancer patients struggles with huge drug costs

Deterioration in brain function following breast cancer therapy affects quality of life: Study

GENova Biotherapeutics signs collaboration deal with Beckpharma

Coffe Break campaign by Alzheimer Society to raise funds to support people with dementia

The Ontario Government must act to reduce the financial barrier to mental health services: MFH

CHUM installs CyberKnife system for effective cancer treatment in Canada

Advancing brain microphysiological systems (bMPS)

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

Latest News